IFPMA Director General concerned about future antibiotics: The pipeline looks "grim"
Thomas Cueni, director general at the global trade association IFPMA uses the word "grim" to describe the antibacterial pipeline currently under clinical development. He hopes this picture can be changed through the newly established antibiotics fund, AMR Action Fund.
BY KEVIN GRØNNEMANN, TRANSLATED BY NIELSINE NIELSEN
Log in to read our articles
Welcome to MedWatch. A part of our content is exclusive and reserved for our users.